Mar 10, 2022
Guts UK has launched a survey on the future of irritable bowel syndrome (IBS) research in the UK. Guts UK and the British Society of Gastroenterology are currently funding a Priority Setting Partnership (PSP) to identify and prioritise the unanswered questions in IBS....
Dec 22, 2021
Many IBS sufferers avoid certain diets and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms. The researchers...
Dec 17, 2021
4D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announced new faecal microbiome analyses from the completed Phase II trial of Blautix(R) (MRx1234) as a treatment...
Dec 10, 2021
metaMe Health, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Regulora®, the first FDA-authorized treatment of any kind specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults. Treatment of...
Oct 25, 2021
A range of measures to help the NHS recover gastroenterology services and mitigate against surges of COVID-19 are outlined in the latest national report from the Getting It Right First Time (GIRFT) programme, which can be downloaded here. Hospital...
